Consensus Santhera Pharmaceuticals Holding AG

Equities

SANN

CH1276028821

Market Closed - Swiss Exchange Other stock markets 11:30:44 2024-05-03 am EDT			5-day change	1st Jan Change
9.31 ^CHF	-0.64%		-2.00%	-5.10%

Apr. 25	Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024
Apr. 25	Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows	MT

Evolution of the average Target Price on Santhera Pharmaceuticals Holding AG

Price target over the last 5 years

History of analyst recommendation changes

2e6bfa928f0a38ffaa3ea8d25f74e2e.PgX8JpS_b9MsS-bqOptfhhKTuStXPtydIFO6CeIyDzo.WX-yZ-fSBaZIEbKZQ6IexGik82IiT6TuE2WXRZRkY215TrVs8v4YgmI6iQ~e7392adb3e0ffef052c350cd4408f556

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

9.31 CHF

Average target price

30 CHF

Spread / Average Target

+222.23%

High Price Target

30 CHF

Spread / Highest target

+222.23%

Low Price Target

30 CHF

Spread / Lowest Target

+222.23%

Consensus detail

Consensus revision (last 18 months)

Quarterly revenue - Rate of surprise

Company calendar